BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 2, 2006
View Archived Issues
MCB-3837 and MCB-3681 yield promising results against Gram-positive strains
Read More
Dong-A expects to commence phase I development of DA-7218 in 2006
Read More
Bristol-Myers Squibb completes rolling NDA for dasatinib
Read More
YM-477: new orally active TPO agonist
Read More
Johnson & Johnson and Guidant merger statement declared effective
Read More
Candidate drug selected in Medivir's HCV collaboration with Tibotec
Read More
Phase IIa study begins for topical PTH (1-34)
Read More
Update on Maxim and EpiCept merger
Read More
sanofi-aventis and Regeneron amend VEGF Trap agreement
Read More
NitroMed and Boston Scientific conclude research collaboration
Read More
Novel agents for treating neurodegenerative disorders disclosed in recent Migenix patent
Read More
Recent patents cover novel treatment options for cancer
Read More
Novel agents with potential for the treatment of anxiety, depression, etc.
Read More
Further studies of NPI-0052 presented
Read More
New histamine H3 receptor ligands emerge from Banyu R&D
Read More
Primary endpoint data from phase II/III trial for Dynavax's Heplisav
Read More
LY-517717: A novel prophylactic for VTE following major orthopedic surgery
Read More
FDA approval for Vaprisol in euvolemic hyponatremia
Read More
EDO-P4 demonstrates broad antifungal activity
Read More
Genentech submits BLA for Lucentis in wet AMD
Read More
Data from several lenalidomide studies presented
Read More